- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Inverted Papilloma in Australia
Total 147 results
-
Antiva BiosciencesTerminatedHIV Infection | Anal Cancer | Human Papilloma Virus Infection | HSIL, High-Grade Squamous Intraepithelial Lesions | Anus NeoplasmUnited States, Australia
-
Head and Neck Cancer International GroupCompletedHead and Neck Squamous Cell Carcinoma | Extranodal Extension | Human Papilloma Virus Related CarcinomaSwitzerland, United Kingdom, United States, Germany, Australia, France, Spain, Denmark
-
Murdoch Childrens Research InstituteBrockhoff Foundation Australia; Shepherd Foundation AustraliaCompleted
-
Peter MacCallum Cancer Centre, AustraliaNational Health and Medical Research Council, Australia; University of MelbourneRecruitingHematologic Diseases | Inherited Platelet Disorder | Inherited BMF SyndromeAustralia
-
Antiva BiosciencesCompletedHIV Infection | Anal Cancer | Anus Neoplasms | Human Papilloma Virus Infection | HSIL, High-Grade Squamous Intraepithelial LesionsUnited States, Australia
-
Becton, Dickinson and CompanyFGK Clinical Research GmbHCompletedPeripherally Inserted Central CatheterGermany, Czechia, Austria, Belgium, Denmark, Italy, Netherlands, Spain, Switzerland
-
Antiva BiosciencesCompletedCervical Cancer | Cervical Intraepithelial Neoplasia | CIN | Human Papilloma Virus | Cervical Dysplasia | HSIL of Cervix | Cervical Neoplasm | HSIL | High-Grade Squamous Intraepithelial Lesions | High-grade Cervical Intraepithelial NeoplasiaUnited States, Australia
-
BayerTerminatedHemophilia A and BAustralia, United Kingdom, Taiwan, Japan, Korea, Republic of, Austria, Bulgaria, Hungary, Italy, France, New Zealand
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UnknownHemophiliaNetherlands, Austria, Australia, Belgium, Canada, Finland, Germany, Italy, Spain, United Kingdom
-
Medical University of ViennaCompleted
-
Spark TherapeuticsCompletedHematologic Diseases | Hemophilia A | Blood Coagulation Disorders, Inherited | Coagulation Protein Disorders | Hemorrhagic Disorders | Genetic Diseases, Inborn | Genetic Diseases, X-Linked | Blood Coagulation Disorder | Factor VIII DeficiencyUnited States, Australia, Thailand, Canada
-
FH Campus Wien, University of Applied SciencesMedical University of Vienna; ShireCompleted
-
Spark TherapeuticsChildren's Hospital of Philadelphia; University of Pittsburgh; St. James's Hospital... and other collaboratorsTerminated
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedHemophilia AUnited States, New Zealand, Australia, Hungary, Sweden, Austria, Poland, Romania
-
rEVO BiologicsCompletedAntithrombin III DeficiencyUnited States, France, United Kingdom, Germany, Canada, Austria, Australia, Italy
-
Hoffmann-La RocheChugai PharmaceuticalCompletedHemophilia AUnited States, Belgium, Spain, Japan, Poland, Australia
-
Tirol Kiniken GmbHLFB BIOMEDICAMENTSUnknown
-
Baxalta now part of ShireCompletedVon Willebrand DiseaseUnited States, Spain, Australia, Taiwan, Czechia, Turkey, Ukraine, Netherlands, Italy, United Kingdom, Austria, Germany, Russian Federation
-
CSL BehringCompletedHemophilia BGermany, Australia, Italy, Israel, Czech Republic, Spain, France, Canada, Austria, Russian Federation
-
Janssen Research & Development, LLCRecruitingInherited Retinal DiseasesUnited States, Korea, Republic of, Canada, Spain, Denmark, Germany, France, Italy, Israel, Austria, United Kingdom
-
NovartisCompletedMyelodysplastic Syndromes | Hemoglobinopathies | Diamond-Blackfan Anemia | Transfusional Iron Overload | Other Inherited or Acquired Anaemia | MPD Syndrome | Other Rare AnaemiasAustralia
-
Medical University of ViennaCompleted
-
Bioverativ Therapeutics Inc.Swedish Orphan BiovitrumCompletedSevere Hemophilia AUnited States, Australia, New Zealand
-
Bioverativ Therapeutics Inc.Swedish Orphan BiovitrumCompletedHemophilia BUnited States, United Kingdom, South Africa, Netherlands, Ireland, Australia
-
Baxalta now part of ShireCompletedVon Willebrand DiseaseNetherlands, Spain, United States, Belgium, Australia, United Kingdom, Austria, Italy, Bulgaria, Japan, Poland, Germany, India, Canada, Russian Federation, Sweden
-
BayerCompletedHemophilia AGermany, Spain, Austria, Italy, Slovenia, Greece, Netherlands
-
Bioverativ Therapeutics Inc.CompletedSevere Hemophilia AUnited States, United Kingdom, Australia
-
BayerActive, not recruitingHemophilia ASpain, Germany, Austria, Greece, Italy, Slovenia
-
Hoffmann-La RocheChugai PharmaceuticalCompletedHemophilia AAustralia, Taiwan, Korea, Republic of, France, Germany, Italy, South Africa, Spain, United States, Japan, Ireland, Poland, United Kingdom, Costa Rica
-
BioMarin PharmaceuticalActive, not recruitingHemophilia AUnited States, Australia, Taiwan, Brazil
-
Hoffmann-La RocheActive, not recruitingSevere Hemophilia ACanada, United States, United Kingdom, Belgium, Australia, Austria, Brazil, France, Germany, Israel, Italy, South Africa, Spain, Turkey
-
BayerCompletedHemophilia ASwitzerland, France, Spain, Sweden, Austria, Italy, Belgium, Denmark, Greece, Netherlands
-
CSL BehringTerminatedHemophilia ARussian Federation, Germany, Italy, Austria, Greece
-
PfizerRecruitingHemophilia A | Hemophilia BAustralia, United States, Turkey
-
Archemix Corp.CompletedPurpura, Thrombotic Thrombocytopenic | Von Willebrand Disease Type-2bAustria
-
Spark TherapeuticsActive, not recruitingHemophilia AUnited States, Canada, Australia
-
CSL BehringCompletedVon Willebrand DiseasePoland, Germany, Austria, Greece, United Kingdom
-
Weill Medical College of Cornell UniversityBayer; University Hospital, BonnCompletedHemophilia A | Hemophilia BUnited States, Israel, Australia, Italy, Sweden, Germany, Japan, Netherlands, Taiwan
-
OctapharmaCompletedSevere Hemophilia AGermany, Austria, United Kingdom, Bulgaria
-
CSL BehringCompletedCongenital Hemophilia AUnited States, Austria, Germany, Malaysia, Netherlands, Philippines, Ukraine, Romania, Spain, Australia, France, Georgia, Italy, Lebanon, Poland, Portugal, Switzerland, Thailand, Turkey
-
Vega Therapeutics, IncRecruitingVon Willebrand DiseasesUnited States, Austria, South Africa, United Kingdom
-
Baxalta now part of ShireCompletedHemophilia AUnited States, Spain, Netherlands, Australia, Czechia, Korea, Republic of, Poland, Germany, Taiwan, Israel, Ukraine, United Kingdom, Malaysia, Japan, Austria, Switzerland, Sweden, Bulgaria, Lithuania, Romania
-
Bioverativ Therapeutics Inc.Swedish Orphan BiovitrumCompletedSevere Hemophilia AUnited States, United Kingdom, Spain, Hong Kong, Israel, New Zealand, Sweden, Australia, Brazil, Japan, Austria, Belgium, Italy, India, Switzerland, Canada, France, Germany, South Africa
-
PfizerActive, not recruitingHemophilia BUnited States, Canada, Australia, Turkey
-
Novo Nordisk A/STerminatedHealthy | Congenital Bleeding Disorder | Haemophilia AAustria, Spain, United Kingdom, France, Germany
-
Spark TherapeuticsCompletedHemophilia AUnited States, Australia, Canada, Israel, Thailand
-
PfizerActive, not recruitingHemophilia BGermany, United Kingdom, Canada, Australia, Taiwan, Japan, France, Turkey, Korea, Republic of, United States, Brazil, Greece, Saudi Arabia, Sweden
-
Bioverativ Therapeutics Inc.Swedish Orphan BiovitrumCompletedSevere Hemophilia BSweden, United States, France, Italy, Russian Federation, United Kingdom, Germany, China, Poland, Japan, Australia, Brazil, Canada, India, South Africa, Hong Kong, Belgium
-
CSL BehringCompletedHemophilia BUnited States, Australia, Japan, France, Philippines, Spain, Czechia, Israel, Canada, Germany, Austria, Bulgaria, Italy, Malaysia, South Africa